Kewaunee Scientific Corporation held its 2025 Annual Shareholder Meeting virtually on August 27, 2025. During the meeting, the management discussed the highlights from the recently completed fiscal year, which ended on April 30, 2025. The company reported exceptional performance with sales reaching $240.5 million, marking an 18.0% increase from the previous year. Pre-tax earnings were $14.8 million, while net earnings were $11.4 million. The management also emphasized the contributions of their global team and channel partners in achieving these results. For more detailed financial information and strategic updates, shareholders can access the full speech and other materials in the investor information section of Kewaunee's website. Unfortunately, the document does not provide a specific URL for direct access to these materials.